EPIGENOME TECHNOLOGIES, INC.

San Diego, CA · Biotech · Private

Paired-Tag, an ultra-high throughput single-cell multi-omics assay kit for simultaneous transcriptome and histone modification analysis

Claim this profile

Follows are private to you and power your alerts

Updated · epigenome.us

Sector
Biotech
Headquarters
San Diego, CA
Total capital
$6.1M
Federal grants
$6.1M
8 awards · 2021–2025
Rank in peer group#9 of 42
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
$35K
2 awards · Health and Human S
Rank in Biotech#362 of 4373
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

20212022202320242025FEDERAL ↑EQUITY ↓Cumulative $6.1M$895K$499K$1.1M$825K$995K$965K
20212022202320242025FEDERAL ↑EQUITY ↓Cumulative $6.1M$895K$1.1M$995K$965K

Latest events

  • Federal grantHealth and Human S · Phase II · Single-cell Epigenome Analysis of the Alzheimer's Disease Brain$965K
  • Federal grantHealth and Human S · Phase II · Single-cell Epigenome Analysis of the Alzheimer's Disease Brain$995K
  • Federal grantHealth and Human S · Phase II · High-throughput Single Cell Co-assay of Histone Modifications andTranscriptome$825K
  • Federal contractHealth and Human S · Laboratory Services - Paired-tag Sample Library Prep.$19K
  • Federal grantHealth and Human S · Phase I · Broadly Accessible Technologies for Single-cell Joint Analysis of Transcriptome and Epigenome$445K
  • Federal grantHealth and Human S · Phase II · High-throughput Single Cell Co-assay of Histone Modifications andTranscriptome$1.1M
  • Federal contractHealth and Human S · Testing Laboratories And Services - Paired-tag Sample Library Preparation$16K
Show 3 earlier federal awards
  • Federal grantHealth and Human S · Phase I · Single-cell Epigenome Analysis of the Alzheimer's Disease Brain$499K
  • Federal grantHealth and Human S · Phase I · Broadly Accessible Technologies for Single-cell Joint Analysis of Transcriptome and Epigenome$895K
  • Federal grantHealth and Human S · Phase I · High-throughput Single Cell Co-assay of Histone Modifications and Transcriptome$350K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 42 peers

Line = median

Biotech · Instrument

  • Federal grants#9 · top 21%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

  • BIOVINC, LLCSimilar federal contract value in Biotech · $45K in contracts
  • Vaxxinity, Inc.Similar federal contract value in Biotech · $39K in contracts
  • CELL BIOLOGICS INCSimilar federal contract value in Biotech · $37K in contracts
  • G-SPACE INCSimilar federal contract value in Biotech · $35K in contracts
  • Epicypher, Inc.Similar federal contract value in Biotech · $33K in contracts
  • Day One BiopharmaceuticalsSimilar federal contract value in Biotech · $26K in contracts

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .